Navigation Links
OHK Medical Devices & Mitsubishi Corp. to Launch HemaClear® in Japan
Date:6/13/2013

Haifa, Israel (PRWEB) June 13, 2013

OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile exsanguinating tourniquet device, announced today that it has entered an exclusive agreement with Japan Medicalnext Co., Ltd, a Mitsubishi Corporation company, for the distribution of HemaClear® in Japan. OHK and Japan Medicalnext Co, will formally launch their entry into the Japanese market over the coming months. The Japanese orthopedic devices market, estimated at $1.4billion and growing at an annual rate of about 5%, represents one the largest markets in the world

“We are very excited to enter one of the largest global markets with such a well respected partner,” said Omer Inbar, CEO, OHK Medical Devices. Inbar added that “The introduction of HemaClear® in Japan is an important step in further establishing HemaClear® as a standard of care in the APAC market following our recent launch of HemaClear® in South Korea, Australia, and Thailand

“We are very excited to launch this new tourniquet technology in the Japanese market,” said Takeru Fujihashi, Vice President of Orthopedic Division, Japan Medicalnext Co., Ltd. “The technology will lead a major change in the current procedure and will create new benefits to the market.” Hemaclear® will be represented by the orthopedic implant division of Japan Medicalnext co., which includes 50 sales representative selling both external and internal fixation technologies.

About HemaClear®

HemaClear® is the world’s leading sterile tourniquet with a simple yet innovative technology, representing a new standard of care in bloodless orthopedic surgery. Since entering the market in 2007 this product has been successfully used in more than 500,000 procedures. HemaClear® represents the first significant advancement in tourniquet technology in over 100 years. HemaClear® was developed by OHK Medical Devices (OHK), a privately held company based in Haifa, Israel and the United States and is currently used in over 2000 operating rooms across 30 countries. For more information about HemaClear®, visit http://www.hemaclear.com.

About Japan Medicalnext Co., Ltd.

Company was originally established in 1992, and was taken over by Mitsubishi Corporation in 2012. Then, Company changed company name as “Japan Medicalnext Co., Ltd.”, and made a new start. Company’s mission is to optimize quality of life for patients by providing new technology and new medical devices. http://www.j-mednext.co.jp.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10821754.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Physician Groups Call for Fewer Medical Tests
2. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
3. CAM therapy combined with conventional medical care may improve treatment of lower back pain
4. Image share project gives patients and physicians anytime, anywhere access to medical images
5. Researchers determine vitamin D blood level for reducing major medical risks in older adults
6. Biomedical researchers receive Hartwell Foundation awards
7. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
8. Fitness in Middle Age Lowers Medical Costs Later: Study
9. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
10. Gene Tests May Not Drive Patients to More Medical Care
11. University studies and career expectations of medical students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... As an ... an educational webinar, they will present the line of epMotion automated liquid handling ... easy you can automate everyday pipetting tasks. , Ideal for scientists and lab ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... assistance that serves communities throughout southern Florida, is working to support the Take ... to children from low income families. , The Take Stock In Children Foundation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... of highly trained practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, ... hormone imbalance and conditions of aging, such as menopause, andropause, thyroid disorder and ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... “Our Mountains ... potent tale of a couple that grew stronger together through the faith they shared ... Faith Through Trials” is the creation of published author, Barbara J. Corcoran, a retired ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin Care ... skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “We ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... DUBLIN , Aug. 7, 2017  Endo International ... has reached agreements to resolve virtually all known U.S. ... in discussions to resolve the known remaining U.S. claims ... installment payments beginning in the fourth quarter of 2017 ... part of its second quarter 2017 results, the Company ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, ... company active in the biopharmaceutical, nutraceutical, and aquacultural ... development of its lead drug candidates, AGR131.  This ... proinflammatory cytokine from the blood of patients suffering ... and inflammatory bowel disease. ...
(Date:8/2/2017)... Calif. , Aug. 2, 2017 ... Continental Who,s Who as a Pinnacle Lifetime Professional ... the Key Account Manager at Turing Pharmaceuticals, AG. ... negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience as ...
Breaking Medicine Technology: